-- 
Eurogerm, France Telecom, LVL Medical: French Equity Preview

-- B y   A n d r e w   R o b e r t s
-- 
2011-06-08T04:00:01Z

-- http://www.bloomberg.com/news/2011-06-07/eurogerm-france-telecom-lvl-medical-french-equity-preview.html
The following is a list of companies
whose stocks may have unusual changes in Paris. Symbols are in
parentheses after company names and prices are from the last
close.  France’s CAC 40 Index rose 0.2 percent to 3,871.92. The
broader SBF 120 Index also advanced 0.2 percent to 2,929.19.  Eurogerm (ALGEM)  SA: The maker of food ingredients said
it formed a joint venture with Nisshin Seifun in China. The
shares were unchanged at 14.61 euros.  France Telecom SA (FTE)  : Chief Executive Officer
Stephane Richard defended the company’s dividend after criticism
from trade unions. The 1.40 euro ($2.05) a share payout, which
represented about 45 percent of 2010 free cash flow, “is on the
same basis as that of all the major listed telecom operators,”
he said. The shares gained 0.1 percent to 15.30 euros.  LVL Medical Groupe SA (LVL)  : Malakoff Mederic owns 10.29
percent of the home health-care company, Autorite des Marches
Financieres said. The shares climbed 1.9 percent to 17.94 euros.  Manitou Group (MTU FP): The industrial-vehicle maker said
Serge Bosche, vice president of sales and marketing for the
Americas region, resigned effective June 30. Daniel Miller,
president of the Compact division, will take over his duties
until a replacement can be found, the company said. The shares
fell 0.2 percent to 20.85 euros.  Meetic (MEET)  SA: FMR LLC cut its voting right stake in
the operator of Europe’s largest online dating network to 4.58
percent, Autorite des Marches Financieres said. The shares rose
0.1 percent to 14.97 euros.  Vetoquinol SA (VETO)  : The diagnostic tests maker said it
bought Farmagricola SA in Brazil. The shares declined 0.2
percent to 30.15 euros.  To contact the reporter on this story:
 Andrew Roberts  in Paris at 
 Aroberts36@bloomberg.net .  To contact the editor responsible for this story:
Celeste Perri at 
 cperri@bloomberg.net . 